Full results & analysis
Available in the Gosset platform where reported.
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension and hypercholesterolemia comparing BR1018A-1 + BR1018B + BR1018C, BR1018A + BR1018B-1 + BR1018C and BR1018A-1 + BR1018B + BR1018C-1 (3 arms). Primary endpoints: Mean sitting systolic blood pressure at 8 weeks and Low-density lipoprotein cholesterol at 8 weeks. Started Apr 2024; status: completed.
02
Design
3 arms- Study design
- RandomizedDouble-blind
BR1018A-1 + BR1018B + BR1018C
Experimental arm
BR1018A + BR1018B-1 + BR1018C
Active comparator arm
BR1018A-1 + BR1018B + BR1018C-1
Active comparator arm
03
Who it enrols
Patients with essential hypertension and primary hypercholesterolemia, with specific blood pressure and lipid profile criteria.
04
Endpoints
Primary
Mean sitting systolic blood pressure
Low-density lipoprotein cholesterol
Beyond the preview
Go deeper on NCT06165250.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06165250.